Xin-hua Liu

State Key Laboratory Of Oral & Maxillofacial Reconstruction And Regeneration, Key Laboratory Of Oral Biomedicine Ministry Of Education, Hubei Key Laboratory Of Stomatology, Wuhan 430079, PR China
Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Corrigendum to 'Engineered Bdellovibrio bacteriovorus enhances antibiotic penetration and biofilm eradication' [Journal of Controlled Release 380 (2025) 283-296].

Corrigendum to 'Engineered Bdellovibrio bacteriovorus enhances antibiotic penetration and biofilm eradication' [Journal of Controlled Release 380 (2025) 283-296].

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: August 06, 2026

A Mito-targeted, pH-sensitive type I photosensitizer for the diagnosis and therapy in bone metastasis of triple negative breast cancer by activating pyroptosis pathway.

A Mito-targeted, pH-sensitive type I photosensitizer for the diagnosis and therapy in bone metastasis of triple negative breast cancer by activating pyroptosis pathway.

Journal: Biosensors & bioelectronics

Published: February 13, 2025

Discovery of quinazoline derivatives as RIPK3 inhibitors that switch cell death from necroptosis to apoptosis for psoriasis treatment.

Discovery of quinazoline derivatives as RIPK3 inhibitors that switch cell death from necroptosis to apoptosis for psoriasis treatment.

Journal: European journal of medicinal chemistry

Published: February 03, 2025

Engineered Bdellovibrio bacteriovorus enhances antibiotic penetration and biofilm eradication.

Engineered Bdellovibrio bacteriovorus enhances antibiotic penetration and biofilm eradication.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: August 31, 2024

FAK inhibitors in cancer, a patent review - an update on progress.

FAK inhibitors in cancer, a patent review - an update on progress.

Journal: Expert opinion on therapeutic patents

Published: July 01, 2024

The intramolecular SN2 reaction tautomeric ent-Kauranoids isolated from the aerial parts of Isodon amethystoides.

The intramolecular SN2 reaction tautomeric ent-Kauranoids isolated from the aerial parts of Isodon amethystoides.

Journal: Fitoterapia

Published: October 25, 2023

Harnessing in situ glutathione for effective ROS generation and tumor suppression via nanohybrid-mediated catabolism dynamic therapy.

Harnessing in situ glutathione for effective ROS generation and tumor suppression via nanohybrid-mediated catabolism dynamic therapy.

Journal: Biomaterials

Published: October 20, 2021

A near infrared ratiometric platform based π-extended porphyrin metal-organic framework for O2 imaging and cancer therapy.

A near infrared ratiometric platform based π-extended porphyrin metal-organic framework for O2 imaging and cancer therapy.

Journal: Biomaterials

Published: January 14, 2021

Synthesis and in vitro and in vivo anti-inflammatory activity of novel 4-ferrocenylchroman-2-one derivatives.

Synthesis and in vitro and in vivo anti-inflammatory activity of novel 4-ferrocenylchroman-2-one derivatives.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: September 19, 2019

Design and synthesis of celastrol derivatives as anticancer agents.

Design and synthesis of celastrol derivatives as anticancer agents.

Journal: European journal of medicinal chemistry

Published: January 26, 2015

Design and synthesis of novel 2-pyrazoline-1-ethanone derivatives as selective MAO inhibitors.

Design and synthesis of novel 2-pyrazoline-1-ethanone derivatives as selective MAO inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: October 29, 2014

New coumarin derivatives: design, synthesis and use as inhibitors of hMAO.

New coumarin derivatives: design, synthesis and use as inhibitors of hMAO.

Journal: Bioorganic & medicinal chemistry

Published: January 16, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026